Abstract
INTRODUCTION: Acute kidney injury (AKI) is a significant complication in burn patients, associated with increased morbidity and mortality. While contrast-enhanced imaging is often essential in trauma care, concerns about contrast-induced nephropathy (CIN) can limit its use. This study examines the occurrence of AKI in burn patients, considering not only contrast exposure but also injury severity, pre-existing illness, and resuscitation practices. METHODS: A retrospective chart review of burn patients who required fluid resuscitation at a burn center was performed. Resuscitation was managed using a clinical decision support tool that provided real-time, patient-specific fluid recommendations, aiming to optimize outcomes while minimizing the risks of under-resuscitation and fluid overload. RESULTS: Of the 50 patients reviewed, 10 underwent contrast-enhanced imaging, with 4 developing AKI and 6 remaining unaffected. Notably, an additional 6 patients who did not receive contrast also developed AKI. Patients who developed AKI (n = 10) were older, had more extensive burns, more co-morbidities, more frequent inhalation injuries, and required greater fluid resuscitation. AKI was associated with significant morbidity, with 4 patients requiring Continuous Renal Replacement Therapy (CRRT) and 4 deaths observed. Documented AKI etiologies included present on admission (n = 4), vancomycin-associated (n = 2), and multifactorial causes (n = 4). CONCLUSIONS: This study suggests that AKI in burn patients is multifactorial and not solely attributable to contrast exposure. The use of nephrotoxic medications, pre-existing renal compromise, infection, and hemodynamic instability play equally or more significant roles in AKI development. Avoiding contrast-enhanced imaging may therefore be an overly cautious approach that risks delaying essential diagnostic evaluations. APPLICABILITY OF RESEARCH TO PRACTICE: This study highlights the importance of a comprehensive assessment when evaluating renal risk in burn patients. Contrast-enhanced imaging should not be withheld when clinically necessary, provided renal risk is managed through careful monitoring, minimization of nephrotoxins, and optimized resuscitation. FUNDING FOR THE STUDY: N/A.